margin assessment
Recently Published Documents


TOTAL DOCUMENTS

401
(FIVE YEARS 157)

H-INDEX

33
(FIVE YEARS 4)

2021 ◽  
Author(s):  
Chen Lin ◽  
Kai-yue Wang ◽  
Hailang Chen ◽  
Yuhua Xu ◽  
Tao Pan ◽  
...  

Abstract Specimen mammography is one of the widely used intraoperative methods assessing margin status in breast conserving surgery. We performed a meta-analysis to evaluate the diagnostic accuracy of specimen mammography. Literature databases including Pubmed, Cochrane Library, Web of Science and EMBASE were searched prior to May 2020. 18 studies with a total of 1142 patients were included. Data was extracted to perform pooled analysis, heterogeneity testing, threshold effect testing, sensitivity analysis, publication bias analysis and subgroup analyses. The pooled weighted values were a sensitivity of 0.55 (95% CI, 0.45–0.64), a specificity of 0.85 (95% CI, 0.77–0.90), a DOR of 7 (95% CI, 4–11) and a pooled positive likelihood ratio of 3.6 (95% CI 2.4-5.3). The area under the receiver operator characteristic curve was 0.75 (95% CI 0.71-0.78). In the subgroup analysis, the pooled specificity in the positive margin defined as tumor at margin subgroup was lower than the other positive margin definition subgroup (0.79 [95% CI: 0.66, 0.91] vs. 0.88 [95% CI: 0.81, 0.95], p = 0.01). Our findings indicated specimen mammography to be an accurate and intraoperative imaging technique for margin assessment in breast conserving surgery.


2021 ◽  
Author(s):  
Uttam M. Pal ◽  
Arif Mohd Kamal ◽  
Ashika Nayak ◽  
Tejaswi Medisetti ◽  
Hardik J. Pandya

2021 ◽  
Vol 108 (Supplement_9) ◽  
Author(s):  
Scarlet Nazarian ◽  
Ioannis Gkouzionis ◽  
Michal Kawka ◽  
Nisha Patel ◽  
Ara Darzi ◽  
...  

Abstract Background Diffuse reflectance spectroscopy (DRS) is a technique that allows discrimination of normal and abnormal tissue based on spectral data. It is a promising technique for cancer margin assessment. However, application in a clinical setting is limited by the inability of DRS to mark the tissue that has been scanned and its lack of continuous real-time spectral measurements. This aim of this study was to develop a real-time tracking system to enable localisation of the tip of a handheld DRS probe to aid classification of tumour and non-tumour tissue. Methods A coloured marker was attached to the DRS fibre probe and was detected using colour segmentation. A Kalman filter was used to estimate the probe’s tip position during scanning of the tissue specimen. In this way, the system was robust to partial occlusion allowing real-time detection and tracking. Supervised classification algorithms were used for the discrimination between tumour and non-tumour tissue, and evaluated in terms of overall accuracy, sensitivity, specificity, and the area under the curve (AUC). A live augmented view with all the tracked and classified optical biopsy sites were presented, providing visual feedback to the surgeons. Results A green coloured marker was successfully used to track the DRS probe. The measured root mean square error of probe tip tracking was 1.18±0.58mm and 1.05±0.28mm for the X and Y directions, respectively, whilst the maximum measured error was 1.76mm. Overall, 47 distinct sets of tumour and non-tumour tissue data were recorded through real-time tracking of ex vivo oesophageal and gastric tissue. The overall diagnostic accuracy of the system to classify tumour and non-tumour tissue in real-time was 94% for stomach and 96% for the oesophagus. Conclusions We have been able to successfully develop a real-time tracking system for a DRS probe when used on stomach and oesophageal tissue for tumour detection, and the accuracy derived demonstrates the strength and clinical value of the technique. The method allows real-time tracking and classification with short data acquisition time to aid margin assessment in cancer resection surgery.


2021 ◽  
Vol 19 (12) ◽  
pp. 1382-1394
Author(s):  
Chrysalyne D. Schmults ◽  
Rachel Blitzblau ◽  
Sumaira Z. Aasi ◽  
Murad Alam ◽  
James S. Andersen ◽  
...  

The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.


2021 ◽  
Vol 33 ◽  
pp. S148-S149
Author(s):  
T.J. Van Oostenbrugge ◽  
N.S. De Jager ◽  
T. Pätz ◽  
S.F.M. Jenniskens ◽  
J.J. Fütterer ◽  
...  

Author(s):  
Krishan Parashar ◽  
Angeli Eloise Torres ◽  
Wyatt Boothby-Shoemaker ◽  
Indermeet Kohli ◽  
Jesse Veenstra ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document